Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Temozolomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 262 Glioma 108 Brain Neoplasms 104 Gliosarcoma 83 Central Nervous System Neoplasms 63 Astrocytoma 61 Melanoma 46 Oligodendroglioma 44 Neuroblastoma 28 Recurrence 22 Neoplasm Metastasis 18 Neoplasms 16 Medulloblastoma 16 Ependymoma 16 Sarcoma, Ewing 13 Lymphoma 13 Sarcoma 12 Rhabdomyosarcoma 11 Neuroendocrine Tumors 11 Lung Neoplasms 11 Diffuse Intrinsic Pontine Glioma 10 Small Cell Lung Carcinoma 9 Neuroectodermal Tumors, Primitive 7 Colorectal Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Osteosarcoma 6 Pinealoma 5 Optic Nerve Glioma 5 Choroid Plexus Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5

Interventions

Diathermy 20 Radiotherapy 11 Fluorouracil 4 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Hyperthermia, Induced 2 Conization 2 Capecitabine 2 spartalizumab 1 anlotinib 1 Temozolomide 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06271421 2024-02-26

ANCHIALE

Poznan University of Medical Sciences

Phase NA Recruiting

Hyperthermia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡